Gimv logo

Gimv

Europe, Antwerpen, Belgium, Antwerpen

Description

Gimv is a European private equity firm that invests in selected investment platforms with a focus on Benelux, France, and Germany.

Investor Profile

Gimv has made 189 investments, with 4 in the past 12 months and 32% as lead.

Stage Focus

  • Series B (23%)
  • Series Unknown (21%)
  • Series A (16%)
  • Series C (15%)
  • Private Equity (14%)
  • Series D (6%)
  • Series E (2%)
  • Series F (1%)
  • Seed (1%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (24%)
  • Belgium (23%)
  • France (15%)
  • The Netherlands (13%)
  • United Kingdom (7%)
  • Germany (6%)
  • Switzerland (5%)
  • Ireland (2%)
  • Israel (1%)
  • Canada (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Software
  • Therapeutics
  • Manufacturing
  • Medical Device
  • Pharmaceutical
  • Biopharma
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gimv frequently co-invest with?

3i Group
Europe, England, United Kingdom, London
Co-Investments: 10
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 8
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 8
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 13
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 10
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 16
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 17
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 16
Forward Ventures
North America, California, United States, San Diego
Co-Investments: 8
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 9

Which angels does Gimv often collaborate with?

FC
North America, Florida, United States, Boca Raton
Shared Deals: 1
LF
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Dave Marver
North America, Washington, United States, Seattle
Shared Deals: 1
JB
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Shared Deals: 1
PC
Europe, Geneve, Switzerland, Geneva
Shared Deals: 1
JM
North America, Massachusetts, United States, Boston
Shared Deals: 1
GC
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
RO
North America, Iowa, United States, Des Moines
Shared Deals: 1
KD
Europe, Vaud, Switzerland
Shared Deals: 1

What are some of recent deals done by Gimv?

FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownJan 7, 2025
Amount Raised: $120,000,000
Kivu Bioscience

San Francisco, California, United States

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

BiotechnologyHealth CareOncology
Series AOct 28, 2024
Amount Raised: $92,000,000
ImmunOs Therapeutics

Schlieren, Zurich, Switzerland

ImmunOs Therapeutics is a clinical-stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series CSep 17, 2024
Amount Raised: $11,000,000
Curana

Ardooie, West-Vlaanderen, Belgium

Curana is a manufacturer of bike equipment and accessories.

AutomotiveManufacturingProduct Design
Private EquityJul 2, 2024
Onward

Eindhoven, Noord-Brabant, The Netherlands

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

BiotechnologyHealth CareMachinery ManufacturingMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 20, 2024
Amount Raised: $21,875,113
Onera Health

Eindhoven, Noord-Brabant, The Netherlands

Onera Health is a global leader in sleep diagnostics and monitoring.

Health CareHealth DiagnosticsMedicalMedical DeviceNanotechnologyWearables
Series CJan 16, 2024
Amount Raised: $32,635,691
ERS

Munich, Bayern, Germany

ERS is a semiconductor manufacturing company that offers thermal wafer testing and Air-Cool technology services.

Industrial ManufacturingInformation TechnologyManufacturingSemiconductor
Private EquityJun 1, 2023
Complement Therapeutics

London, England, United Kingdom

Complement Therapeutics operates as a preclinical stage company.

BiotechnologyMedical
Series AApr 17, 2023
Amount Raised: $78,657,148
Mediar Therapeutics

Cambridge, Massachusetts, United States

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

BiotechnologyHealth CareMedicalTherapeutics
Series AMar 15, 2023
Amount Raised: $85,000,000
FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownMar 15, 2023
Amount Raised: $25,000,000